Automized inline monitoring in perfused mammalian cell culture by MIR spectroscopy without calibration model building

Author:

Marienberg Hannah1,Desch Nicole2,Mozin Vitalii1,Sykora‐Mirle Lorenz1,Müller Anja1ORCID,Roth Andreas13,Käfer Mathias2,Neef Rüdiger2

Affiliation:

1. IRUBIS GmbH Munich Germany

2. Amgen Research (Munich) GmbH Munich Germany

3. Hochschule Mannheim Mannheim Germany

Abstract

AbstractProcess Analytical Technologies (PATs) are taking a key role in the run for automatization in the biopharmaceutical industry. Spectroscopic methods such as Raman spectroscopy or mid‐infrared (MIR) spectroscopy are getting more recognition in the recent years for inline monitoring of bioprocesses due to their ability to measure various molecules simultaneously. However, their dependency on laborious model calibration making them a challenge to implement. In this study, a novel one‐point calibration that requires a single reference point prior to the inline monitoring of glucose and lactate in bioprocesses with MIR spectroscopy is assessed with 22 mammalian cell perfusion (PER) processes in two different scales and four different products. Concentrations are predicted over all PERs runs with a root mean square error (RMSE) of 0.29 g/L for glucose and 0.24 g/L for lactate, respectively. For comparison conventional partial least square regression (PLSR) models were used and trained with spectroscopic data from six bioreactor runs in two different scales and three products. The general accuracy of those models (RMSE of 0.41 g/L for glucose and 0.16 g/L for lactate) are in the range of the accuracy of the one‐point calibration. This shows the potential of the one‐point calibration as an approach making spectroscopy more accessible for bioprocess development.

Funder

Horizon 2020 Framework Programme

Publisher

Wiley

Subject

Bioengineering,Environmental Engineering,Biotechnology

Reference19 articles.

1. Food and Drug Administration (FDA).Guidance for Industry:PAT—A Framework for Innovative Pharmaceutical Development Manufacturing and Quality Assurance.2004.https://www.fda.gov/regulatory‐information/search‐fda‐guidance‐documents/pat‐framework‐innovative‐pharmaceutical‐development‐manufacturing‐and‐quality‐assurance

2. Comparative study of non-invasive monitoring via infrared spectroscopy for mammalian cell cultivations

3. Real time monitoring of multiple parameters in mammalian cell culture bioreactors using an in-line Raman spectroscopy probe

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3